- Overview Press tab for submenu items
TCS is here to make a difference through technology.
Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
Overview
Overview
Overview
Overview
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
- Overview Press tab for submenu items
We’re in it for good, driving positive change for the benefit of all.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
-
About Us
- Overview Press tab for submenu items
Extraordinary expertise leads to remarkable results.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
-
Customer Stories
-
Perspectives
-
Global studies
-
Topics
- Overview Press tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Overview
Overview
Overview
Overview
Overview
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
- Overview Press tab for submenu items
Find the latest news about TCS in our Newsroom
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
-
Press releases
Recent Press releases
View all -
News alerts
-
Analyst recognition
Recent recognitions
View all -
Events
-
Media kit
- Overview Press tab for submenu items
TCS works hand in hand with world-leading investors.
Tata Consultancy Services LimitedNSE:TCSINR -
Management Commentary
-
Financials
-
News and Events
-
ESG
-
Resources
Overview
Overview
Overview
Overview
Overview
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
Top Results
Showing
10
01 - 07
You have these already downloaded
We have sent you a copy of the report to your email again.
Contract Research Organizations (CROs) have evolved and grown to serve the life sciences industry, academia, and research & development organizations, the roots of which are deeply entrenched across diverse aspects of clinical trials.
In today’s data driven world, CROs must invest in digital technologies to improve collaboration across the clinical trial ecosystem and transform services, products, and processes to not only retain but also enhance their leadership over clinical trials conduct.
The ideal CRO digital platform offers an opportunity to un-burden bureaucracy put upon sites today and drive data capture and integrity straight into the digital eco-system allowing earlier intervention, if required, or more rapid conclusion of trials to support registration or go/no-go decisions.
Read this whitepaper to understand the parameters that drive digitalization for the CROs
About the authors
Image of Dr. Alejandra Guerchicoff
Dr. Alejandra Guerchicoff
Dr. Alejandra Guerchicoff is a PhD in molecular genetics with a post-doctoral training in molecular cardiology. She is working as an Industry Advisor for TCS ADD platform with the Life Sciences unit at Tata Consultancy Services (TCS). Dr. Guerchicoff possesses a rich experience of more than 20 years in the domain of clinical research and post-marketing pharmacovigilance, for medical devices, drugs, combination products, gene and cell therapy, and software as medical device products.
Image of Paul Ingram
Paul Ingram
During Dr. Ingram’s 25-year career, his work has focused on pharmaceutical research and development and medical devices. He has over 15 years of experience in clinical supplies, working in both Phase 1 unit manufacturing suites and trial supplies service companies, including Quintiles (later Aptuit), Fisher Clinical and Catalent.
Related reading
1/4
Alejandra Guerchicoff
Next-gen Medical Writing: The Current State and Future Perspective
White Paper
|
10 Jul 2024
Opens in new tab
2/4
Alejandra Guerchicoff
Transforming PV Efficiencies with ML and Rule-based Automation
White Paper
|
18 Aug 2023
Opens in new tab
3/4
Alejandra Guerchicoff
A hybrid approach towards signal management in Pharmacovigilance
White Paper
|
22 Dec 2022
Opens in new tab
4/4
Alejandra Guerchicoff
A beginner’s guide to AI driven pharmacovigilance platform
White Paper
|
22 Dec 2022
Opens in new tab
Transformation starts here
Learn how we can help you bring drugs to the market faster.
Talk to our expertsFind out more
©2024 TATA Consultancy Services Limited
©2024 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?